D
Teva Pharmaceutical Industries Limited TEVA
$15.38 -$0.07-0.45% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 0.29% 1.89% -5.12% 12.52% 7.37%
Total Other Revenue -- -- -- -- --
Total Revenue 0.29% 1.89% -5.12% 12.52% 7.37%
Cost of Revenue -3.08% -1.66% 3.33% 9.20% 2.79%
Gross Profit 3.85% 5.99% -12.25% 16.10% 12.69%
SG&A Expenses 2.13% 3.72% 5.54% 9.48% 3.19%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses 600.00% 111.76% -22.22% -171.43% 95.83%
Total Operating Expenses -1.94% 0.73% 4.05% 7.74% 4.33%
Operating Income 9.42% 7.42% -28.62% 31.93% 21.94%
Income Before Tax 183.27% 162.42% -148.62% -593.85% 73.46%
Income Tax Expenses -112.38% 242.31% -31.71% 675.00% 4,037.50%
Earnings from Continuing Operations 132.23% 152.51% -158.89% -606.49% 3.53%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -102.14% 1,550.00% -487.50% -17.14%
Net Income 133.33% 253.96% -146.87% -733.33% 2.98%
EBIT 9.42% 7.42% -28.62% 31.93% 21.94%
EBITDA 6.41% 2.25% -23.40% 20.98% 10.93%
EPS Basic 132.93% 251.86% -146.37% -726.14% 4.10%
Normalized Basic EPS 1.74% -45.42% -23.78% 38.81% 35.06%
EPS Diluted 132.00% 245.40% -147.46% -750.00% 3.85%
Normalized Diluted EPS 0.49% -46.41% -22.69% 40.54% 35.06%
Average Basic Shares Outstanding 1.24% 1.34% 1.07% 1.07% 1.16%
Average Diluted Shares Outstanding 2.47% 3.21% -0.35% -0.18% 1.16%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --